MULTI-MODALITY NEUROMODULATION OF BRAIN TARGETS

• US 20110130615A1
• Filed: 12/02/2010
• Published: 06/02/2011
• Est. Priority Date: 12/02/2009
• Status: Abandoned Application

• Current Assignee: David J. Mishelevich
• Original Assignee: David J. Mishelevich
• Inventors: Mishelevich, David J.
• Application Number:
  US12/958,411
• Publication Number:
  US 20110130615A1
• Time in Patent Office: Days
• US Class Current: 600/9
• CPC Class Codes: A61B 18/12 by passing a current through the tissue to be heated, e.g. high-frequency current
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36053 adapted for vagal stimulation A61N1/36114 takes precedence
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36078 Inducing or controlling sleep or relaxation non-implantable stimulator A61M21/00
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/36089 Addiction or withdrawal from substance abuse such as alcohol or drugs
• CPC Class Codes: A61N 1/361 Phantom sensations, e.g. tinnitus
• CPC Class Codes: A61N 1/36107 Sexual dysfunction stimulating genital organs A61N1/36007
• CPC Class Codes: A61N 1/36128 Control systems
• CPC Class Codes: A61N 2/002 in combination with another treatment

Abstract

Disclosed are methods and systems and methods for deep or superficial deep-brain stimulation using multiple therapeutic modalities. These impact multiple points in a neural circuit or one or multiple points in multiple neural circuits to produce Long-Term Potentiation (LTP) or Long-Term Depression (LTD) to treat indications such as neurologic and psychiatric conditions. Modality examples are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, RF stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, and drugs. Some targets may be up-regulated and others down-regulated. Coordinated control is provided, as applicable, for control of the direction of the energy emission, intensity, session duration, frequency, pulse-train duration, phase, and numbers of sessions, if and as applicable, for neurormodulation of neural targets. Use of ancillary monitoring or imaging to provide feedback may be applied.

Claims

1. A method of modulating deep-brain targets using multiple therapeutic modalities, the method comprising:

applying a plurality of therapeutic modalities to a deep-brain target,

applying power to each of the on-line therapeutic modalities via a control circuit thereby neuromodulating the activity of the deep brain target regions, and

working in coordination with the off-line therapeutic modalities.

2. The method of claim 1, where the therapeutic modalities are selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

3. The method of claim 1, wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, functional stimulation, and drugs is combined one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation other-implant stimulation, functional stimulation, drugs.

4. The method of claim 1, wherein a disorder is treated by neuromodulation, the method comprising modulating the activity of one target brain region or simultaneously modulating the activity of two or more target brain regions, wherein the target brain regions are selected from the group consisting of NeoCortex, any of the subregions of the Pre-Frontal Cortex, Orbito-Frontal Cortex (OFC), Cingulate Genu, subregions of the Cingulate Gyrus, Insula, Amygdala, subregions of the Internal Capsule, Nucleus Accumbens, Hippocampus, Temporal Lobes, Globus Pallidus, subregions of the Thalamus, subregions of the Hypothalamus, Cerebellum, Brainstem, Pons, or any of the tracts between the brain targets.

5. The method of claim 1, wherein the disorder treated is selected from the group consisting of:

addiction, Alzheimer'"'"'s Disease, Anorgasmia, Attention Deficit Hyperactivity Disorder, Huntington'"'"'s Chorea, Impulse Control Disorder, autism, OCD, Social Anxiety Disorder, Parkinson'"'"'s Disease, Post-Traumatic Stress Disorder, depression, bipolar disorder, pain, insomnia, spinal cord injuries, neuromuscular disorders, tinnitus, panic disorder, Tourette'"'"'s Syndrome, amelioration of brain cancers, dystonia, obesity, stuttering, ticks, head trauma, stroke, epilepsy.

6. The method of claim 1, wherein the multi-modality therapy is applied for the purpose selected from the group consisting of:

cognitive enhancement, hedonic stimulation, enhancement of neural plasticity, improvement in wakefulness, brain mapping, diagnostic applications, and other research functions.

7. The method of claim 1, wherein one or a plurality of targets are hit by a plurality of therapeutic modalities.

8. The method of claim 1, wherein a feedback mechanism is applied, wherein the feedback mechanism is selected from the group consisting of functional Magnetic Resonance Imaging (fMRI), Positive Emission Tomography (PET) imaging, video-electroencephalogram (V-EEG), acoustic monitoring, thermal monitoring.

9. The method of claim 1 where the output is on-line, real time where neuromodulation parameters are changed immediately under direct control of the Treatment Planning and Control System.

10. The method of claim 1 where the on-line, real-time neuromodulators are selected from the group consisting of ultrasound transducers, TMS stimulators.

11. The method of claim 1 where the output is on-line prescriptive where neuromodulation parameters are directly set in programmers and the effect is both reversible and seen immediately.

12. The method of claim 1 where the on-line, prescriptive neuromodulators are selected from the group consisting of on-line, real-time programmable DBS programmers, Vagus Nerve Stimulation programmers, neuromodulators with similar characteristics to DBS programmers, Vagus Nerve Stimulation programmers, other-implant programmers.

13. The method of claim 1 where the output is off-line prescriptive adjustable where instructions are generated for users to adjust programmers and the effect is reversible but the effect is seen at a later time after the programmers have been so adjusted.

14. The method of claim 1 where the off-line, prescriptive adjustable neuromodulators are selected from the group consisting of off-line prescriptive adjustable DBS programmers, Vagus Nerve Stimulation programmers, other-implant programmers, neuromodulators with similar characteristics to DBS programmers, Vagus Nerve Stimulation programmers other-implant programmers.

15. The method of claim 1 where the output is off-line prescriptive permanent where neuromodulation parameters are instructions are generated for users to adjust parameters and the effect is not reversible and the effect is seen at a later time after the change has been made.

16. The method of claim 1 where the off-line, prescriptive permanent neuromodulators are selected from the group consisting of radiosurgery, neuromodulators with characteristics similar to radiosurgery.

17. The method of claim 1 where the treatment planning and control system varies, as applicable, a plurality of elements selected from the group consisting of direction of energy emission, intensity, pulse-train duration, session durations, numbers of sessions, frequency, phase, firing patterns, number of sessions, relationship to other controlled modalities.

18. The method of claim 1 where real-time modalities are applied simultaneously.

19. The method of claim 1 where real-time modalities are applied sequentially.

20. The method of claim 1 where multiple indications are treated simultaneously or sequentially.

21. The method of claim 1 where the multiple conditions have one or more common targets.

22. The method of claim 1 where the multiple conditions have no common targets.

23. A method of modulating deep-brain targets using multiple therapeutic modalities for the treatment of pain, the method comprising:

applying down-regulation via ultrasound to the Dorsal Anterior Cingulate Gyrus,

applying down-regulation via ultrasound to the Cingulate Genu,

applying down-regulation via Transcranial Magnetic Stimulation to the Insula,

applying down-regulation via ultrasound to the Caudate Nucleus, and

applying down-regulation via Deep Brain Stimulation of the Thalamus.

24. The method of claim 23 wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs is replaced by one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

25. The method of claim 23 where alternative targets in an applicable neural circuit are substituted.

26. A method of modulating deep-brain targets using multiple therapeutic modalities for the treatment of depression, the method comprising:

applying down-regulation via ultrasound to the Orbito-Frontal Cortex,

applying up-regulation via ultrasound to the Dorsal Anterior Cingulate Gyrus,

applying down-regulation via ultrasound to the Subgenu Cingulate,

applying down-regulation via ultrasound to the Cingulate Genu,

applying up-regulation via Transcranial Magnetic Stimulation to the right Insula,

applying down-regulation via Transcranial Magnetic Stimulation to the left Insula,

applying up-regulation via Deep Brain Stimulation to the Nucleus Accumbens,

applying up-regulation via ultrasound to the Caudate Nucleus,

applying down-regulation via radiosurgery of the Amygdala, and

applying down-regulation via Deep Brain Stimulation of the Thalamus.

27. The method of claim 26 wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs is replaced by one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

28. The method of claim 26 where alternative targets in an applicable neural circuit are substituted.

29. A method of modulating deep-brain targets using multiple therapeutic modalities for the treatment of addiction, the method comprising:

applying down-regulation via ultrasound to the Orbito-Frontal Cortex,

applying up-regulation via ultrasound to the Dorsal Anterior Cingulate Gyrus,

applying down-regulation via Transcranial Magnetic Stimulation to the Insula,

applying down-regulation via radiosurgery of the Nucleus Accumbens, and

applying down-regulation via Deep Brain Stimulation of the Globus Pallidus.

30. The method of claim 29 wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs is replaced by one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

31. The method of claim 29 where alternative targets in an applicable neural circuit are substituted.

32. A method of modulating deep-brain targets using multiple therapeutic modalities for the treatment of obesity, the method comprising:

applying down-regulation via Transcranial Magnetic Stimulation of the Orbito-Frontal Gyrus,

applying down-regulation via ultrasound to the Hypothalamus,

applying down-regulation via Transcranial Magnetic Stimulation to the Insula, and

applying down-regulation via radiosurgery of the Lateral Hypothalamus.

33. The method of claim 32 wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs is replaced by one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

34. The method of claim 32 where alternative targets in an applicable neural circuit are substituted.

35. A method of modulating deep-brain targets using multiple therapeutic modalities for the treatment of epilepsy, the method comprising:

applying down-regulation via Transcranial Magnetic Stimulation of the Temporal Lobe,

applying down-regulation via radiosurgery of the Amygdala,

applying down-regulation via ultrasound to the Hippocampus,

applying up-regulation via Vagus Nerve Stimulation of the Thalamus, and

applying down-regulation via Deep Brain Stimulation of the Cerebellum.

36. The method of claim 35 wherein a therapy selected from the group consisting of implanted deep-brain stimulation (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, and drugs is replaced by one or more therapies selected from the group consisting of are implanted deep-brain stimulators (DBS), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, focused ultrasound, radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, other-implant stimulation, functional stimulation, drugs.

37. The method of claim 35 where alternative targets in an applicable neural circuit are substituted.